CD274 and cervical carcinoma: Information on molecular factors that might affect cervical cancer outcomes may become an essential part of staging in the foreseeable future. The presence (or absence) of anti-angiogenic factors, such as VEGF-2, and immune checkpoint blockade markers, such as PD-L1, may significantly impact survival than either the local tumor or nodal metastasis [22].